PFIZER INC
For the period ended Sep 28, 2025. Filed Nov 4, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 28, 2025 · Filed Nov 4, 2025
PFE$29.23-0.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| (MILLIONS) | September 28,2025 | December 31, 2024 |
|---|---|---|
| (Unaudited) | ||
| Assets | ||
| Cash and cash equivalents | $1,343 | $1,043 |
| Short-term investments | 13,641 | 19,434 |
| Trade accounts receivable, net of allowance for doubtful accounts: 2025—$434; 2024—$438 | 14,260 | 11,463 |
| Inventories | 11,468 | 10,851 |
| Current tax assets | 3,855 | 3,314 |
| Other current assets | 2,358 | 4,253 |
| Total current assets | 46,924 | 50,358 |
| Long-term investments | 2,137 | 2,228 |
| Property, plant and equipment, net of accumulated depreciation: 2025—$17,505; 2024—$16,483 | 18,880 | 18,393 |
| Identifiable intangible assets, net | 51,324 | 55,411 |
| Goodwill | 69,101 | 68,527 |
| Noncurrent deferred tax assets and other noncurrent tax assets | 11,048 | 8,662 |
| Other noncurrent assets | 9,317 | 9,817 |
| Total assets | $208,731 | $213,396 |
| Liabilities and Equity | ||
| Short-term borrowings, including current portion of long-term debt: 2025—$4,247; 2024—$3,747 | $4,303 | $6,946 |
| Trade accounts payable | 5,024 | 5,633 |
| Dividends payable | — | 2,437 |
| Income taxes payable | 3,799 | 2,910 |
| Accrued compensation and related items | 3,036 | 3,838 |
| Deferred revenues | 924 | 1,511 |
| Other current liabilities | 19,509 | 19,720 |
| Total current liabilities | 36,596 | 42,995 |
| Long-term debt | 57,409 | 57,405 |
| Pension and postretirement benefit obligations | 2,157 | 2,115 |
| Noncurrent deferred tax liabilities | 2,467 | 2,122 |
| Other taxes payable | 3,401 | 6,112 |
| Other noncurrent liabilities | 13,605 | 14,150 |
| Total liabilities | 115,635 | 124,899 |
| Commitments and Contingencies | ||
| Common stock | 481 | 480 |
| Additional paid-in capital | 94,248 | 93,603 |
| Treasury stock | (115,011) | (114,763) |
| Retained earnings | 121,150 | 116,725 |
| Accumulated other comprehensive loss | (8,066) | (7,842) |
| Total Pfizer Inc. shareholders’ equity | 92,801 | 88,203 |
| Equity attributable to noncontrolling interests | 295 | 294 |
| Total equity | 93,096 | 88,497 |
| Total liabilities and equity | $208,731 | $213,396 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.